Companies · Other Health Care

Siloam Vision, Inc.

PORTLAND · Other Health Care

Diligence memoA one-page analyst read on Siloam Vision, Inc. — recommendation, valuation, rhythm, risks.
$3.2M
Total raised · real
5
Rounds
0.5×
Latest step-up
Top 45%
Sector rank · raised
Seed
Latest stage · inferred · Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Siloam Vision, Inc. looks under-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.19× the median modeled value of Seed Other Health Care companies in 2025–2027 (105 peers) — value vs value, same stage and era.
Active
  • Last raise 5 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Siloam Vision, Inc. is one of 5377 Other Health Care companies tracked from PORTLAND. By capital raised it ranks mid-pack (ahead of 56% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
2
Investors (latest)
2021
Year incorporated
2026-01-26
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$2.5M$5.0M$7.5M$10MPre-Seed · 2022-05-12 Raised $500K (real) Modeled valuation $6.1M (est)$500K$6.1MPre-Seed2022Pre-Seed · 2023-02-14 Raised $550K (real) Modeled valuation $4.6M (est)$550K$4.6MPre-Seed2023Seed · 2024-03-05 Raised $1.1M (real) Modeled valuation $5.5M (est)$1.1M$5.5MSeed2024Seed · 2025-01-31 Raised $745K (real) Modeled valuation $2.6M (est)$745K$2.6MSeed2025Seed · 2026-01-26 Raised $350K (real) Modeled valuation $792K (est)$350K$792KSeed2026+$550K+$1.1M+$745K+$350KCumulative $3.2M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$500K · 2022
Pre-Seed extension$550K · 2023
Seed$1.1M · 2024
Seed extension$745K · 2025
Seed extension$350K · 2026

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$792K
Base estimate est.
$296K
Conservative case
$1.4M
Upside case
$1.8M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $6.1M · 2022-05-122022Pre-Seed · modeled $4.6M · 2023-02-14Seed · modeled $5.5M · 2024-03-05Seed · modeled $2.6M · 2025-01-31Seed · modeled $792K · 2026-01-262026
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
0.4 yr
Elapsed time used
0.4 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
11 mo
Avg between rounds
$871K/yr
Capital velocity
4.1 yr
On record since
2022
First round
5
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 1.3× above median
This company$3.2M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.2× of median
This company$350K
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 0.0× of median
This company$792K
Sector median$22.1M

Raised more than 56% of sector peers (real $). Modeled value above 5% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #89 of 105.

This companyCohort peer
$100K$1.0M$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)Xymogen, Inc. · Seed Raised $62.4M · modeled $12.3M (est)Willow Life Sciences, Inc. · Seed Raised $4.0M · modeled $12.0M (est)ManyClicks, Inc. · Seed Raised $4.0M · modeled $11.7M (est)Sterile State, Inc. · Seed Raised $3.2M · modeled $11.5M (est)Limber Prosthetics, Inc. · Seed Raised $3.8M · modeled $11.1M (est)Othership Inc. · Seed Raised $3.7M · modeled $11.1M (est)Ps-Fertility, Inc. · Seed Raised $3.5M · modeled $11.0M (est)Eagle Onsite, Llc · Seed Raised $3.5M · modeled $10.6M (est)ForCast Orthopedics, Inc. · Seed Raised $3.8M · modeled $10.6M (est)1888 Equity LLC · Seed Raised $3.0M · modeled $10.5M (est)Arrellio, Inc. · Seed Raised $3.5M · modeled $10.0M (est)Kindbridge Corp · Seed Raised $5.4M · modeled $9.9M (est)Siloam Vision, Inc. (this company) Raised $3.2M · modeled $792K (est)Siloam Vision, Inc.
CompanyStageRaised · realValue · estvs peer med.
Xymogen, Inc.Seed$62.4M$12.3M2.89×
Willow Life Sciences, Inc.Seed$4.0M$12.0M2.84×
ManyClicks, Inc.Seed$4.0M$11.7M2.75×
Sterile State, Inc.Seed$3.2M$11.5M2.70×
Limber Prosthetics, Inc.Seed$3.8M$11.1M2.63×
Othership Inc.Seed$3.7M$11.1M2.61×
Ps-Fertility, Inc.Seed$3.5M$11.0M2.59×
Eagle Onsite, LlcSeed$3.5M$10.6M2.51×
ForCast Orthopedics, Inc.Seed$3.8M$10.6M2.50×
1888 Equity LLCSeed$3.0M$10.5M2.48×
Arrellio, Inc.Seed$3.5M$10.0M2.35×
Kindbridge CorpSeed$5.4M$9.9M2.33×
Siloam Vision, Inc. this companySeed$3.2M$792K0.19×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$500K2022-05-12$2.8M$6.1M90%
Pre-Seed$550K2023-02-14$3.1M$4.6M90%
Seed$1.1M2024-03-05$5.4M$5.5M90%
Seed$745K2025-01-31$3.7M$2.6M90%
Seed$350K2026-01-26$1.8M$792K90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$500K2022-05-12
    • First recorded raise — entered as Pre-Seed.
    • 3 investors on this round.
  2. Pre-Seed$550K2023-02-14
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 5 investors on this round.
  3. Seed$1.1M2024-03-05
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round 2.0× larger than the prior — scaling up.
    • 8 investors on this round.
  4. Seed$745K2025-01-31
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 8 investors on this round.
  5. Seed$350K2026-01-26
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 2.1× smaller than the prior — bridge or down round.
    • 2 investors on this round.
Intelligence
2026 ~Q4
Modeled next raise · ~11mo cadence
$350K
Modeled next size est.range $350K$560K
0.5×
Last step-up
$871K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Degang Peter Wang2022-05
Degang Wang2023-02
John Peter Campbell2022-05
Karyn Peter Jonas2022-05
Robison Vernon Peter Paul Chan2022-05
Tong Peter Sun2022-05
Registry & provenance

Siloam Vision, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
2087423
SEC CIK
2021
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
DLG & Associates, LLCOther Health CareSeed$3.2M$1.5Msame sector · same stage
Southwest Surgery Center, LLCOther Health CareSeed$3.3M$439Ksame sector · same stage
ReddyPort, Inc.Other Health CareSeed$3.1M$642Ksame sector · same stage
NeuroFine Corp.Other Health CareSeed$3.3M$341Ksame sector · same stage
Cast21, Inc.Other Health CareSeed$3.4M$892Ksame sector · same stage
Charlotte Surgery Center LlcOther Health CareSeed$3.1M$1.3Msame sector · same stage
Waypoint Orthopedics, Inc.Other Health CareSeed$3.6M$640Ksame sector · same stage
PNC Podiatry Holdings, LLCOther Health CareSeed$3.6M$911Ksame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
MediCanna Vision Inc.Other Health CareSeed$4.1M86%
Connecticut Vision Holdings, LLCOther Health CareSeed$25.4M85%
O/D Vision, Inc.Other Health CarePre-Seed$3.4M84%
American Vision Partners Holdings CorpOther Health CarePre-Seed$25.0M84%
Myra Vision, Inc.Other Health CareSeries B$108.8M84%
LENSAR, Inc.Other Health CareSeries B$185.2M84%
Restore Vision Holdings, Inc.Other Health CarePre-Seed$1.5M83%
LensGen, Inc.Other Health CareSeries A$147.1M83%
Frequently asked
How much funding has Siloam Vision, Inc. raised?
Siloam Vision, Inc. has raised approximately $3.2M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Siloam Vision, Inc.'s estimated valuation?
Provath's modeled valuation for Siloam Vision, Inc. is approximately $792K (modeled range $296K–$1.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Siloam Vision, Inc. at?
Siloam Vision, Inc.'s latest modeled financing stage is Seed. Its most recent recorded round closed around Mon Jan 26.
What does Siloam Vision, Inc. do and where is it based?
Siloam Vision, Inc. operates in the Other Health Care sector, based in PORTLAND.
Explore related

See where Siloam Vision, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Siloam Vision, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.